Treatment of Human Malignancies and Immune Disorders
BCT, founded in 2000, is a clinical-stage biopharmaceutical company focused on the research and development of innovative biologics for the treatment of human malignancies and immune disorders.
Learn More
Treatment of Human Malignancies and Immune Disorders
BCT, founded in 2000, is a clinical-stage biopharmaceutical company focused on the research and development of innovative biologics for the treatment of human malignancies and immune disorders.
Learn More